Coya Therapeutics Inc (COYA)
| Sector: | |
| Super Investor Stats: | |
| Ownership count: | 1 |
| Ownership rank: | 667 |
| % of all portfolios: | 0.004% |
| |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
4 |
$106,393 |
| Sells |
0 |
$0 |
Open Market Insider Buys
| Date Filed |
Reporting Name |
Relationship |
Trans. Date |
Shares |
Price $ |
Total Value $ |
| 14 Nov 2024 |
SNYDER DAVID S |
Chief Financial Officer |
14 Nov 2024 |
1,800 |
7.19 |
12,934 |
| 13 Nov 2024 |
SWAMINATHAN ARUN |
Chief Executive Officer |
13 Nov 2024 |
5,000 |
7.36 |
36,797 |
| 12 Nov 2024 |
GROSSMAN FRED |
Chief Medical Officer |
11 Nov 2024 |
2,710 |
7.37 |
19,973 |
| 12 Nov 2024 |
SWAMINATHAN ARUN |
Chief Executive Officer |
11 Nov 2024 |
5,000 |
7.34 |
36,689 |
| 05 Mar 2024 |
LEE ANN |
Director |
22 Aug 2023 |
1,000 |
3.62 |
3,620 |
| 04 Jan 2023 |
GARREN HIDEKI |
Director |
03 Jan 2023 |
2,000 |
0.00 |
0 |
| 04 Jan 2023 |
SNYDER DAVID S |
Chief Financial Officer |
03 Jan 2023 |
7,000 |
0.00 |
0 |
| 04 Jan 2023 |
GOLDSTEIN DOV A MD |
Director |
03 Jan 2023 |
10,000 |
0.00 |
0 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock